Back
SpringWorks Therapeutics Stock Price Chart
Sponsored
SWTX
Sponsored
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.
Sell
29
SWTX
SpringWorks Therapeutics
Last Price:
28.57
Seasonality Move:
39.52%
7 Day Trial
ALL ACCESS PASS
$
7
Escape the market madness with 7 stocks to buy and hold
Get the complete list FREE for a limited time.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SWTX is experiencing selling pressure, which indicates risk of future bearish movement.
SpringWorks Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.42 | Sell |
20-day SMA: | 31.49 | Sell |
50-day SMA: | 35.52 | Sell |
200-day SMA: | 41.09 | Sell |
8-day EMA: | 30.59 | Sell |
20-day EMA: | 31.83 | Sell |
50-day EMA: | 34.26 | Sell |
200-day EMA: | 37.1 | Sell |
SpringWorks Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.48 | Sell |
Relative Strength Index (14 RSI): | 32.12 | Sell |
Chaikin Money Flow: | -483189 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (30.52 - 33.74) | Sell |
Bollinger Bands (100): | (33.31 - 40.03) | Sell |
SpringWorks Therapeutics Technical Analysis
Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 18 | 21 | 22 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
- SpringWorks Therapeutics share price is 29.80 while SWTX 8-day simple moving average is 30.42, which is a Sell signal.
- The stock price of SWTX is 29.80 while SpringWorks Therapeutics 20-day SMA is 31.49, which makes it a Sell.
- SpringWorks Therapeutics 50-day simple moving average is 35.52 while SWTX share price is 29.80, making it a Sell technically.
- SWTX stock price is 29.80 and SpringWorks Therapeutics 200-day simple moving average is 41.09, creating a Sell signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
29
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a Sell
The current SpringWorks Therapeutics [SWTX] share price is $29.80. The Score for SWTX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
2.21B
Price in USD:
29.80
Share Volume:
505.84K
SpringWorks Therapeutics 52-Week Range
52-Week High:
53.92
52-Week Low:
18.00
Sell
29
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?
The SpringWorks Therapeutics stock price is 29.80 USD today. -
Will SWTX stock go up or go down?
SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is SpringWorks Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
- SpringWorks Therapeutics share price is 29.80 while SWTX 8-day exponential moving average is 30.59, which is a Sell signal.
- The stock price of SWTX is 29.80 while SpringWorks Therapeutics 20-day EMA is 31.83, which makes it a Sell.
- SpringWorks Therapeutics 50-day exponential moving average is 34.26 while SWTX share price is 29.80, making it a Sell technically.
- SWTX stock price is 29.80 and SpringWorks Therapeutics 200-day simple moving average is 37.10, creating a Sell signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and an increase next year of $1.54 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
- SWTX Moving Average Covergence Divergence (MACD) indicator is -1.48, suggesting SpringWorks Therapeutics is a Sell
- SpringWorks Therapeutics Relative Strength Index (RSI) is 32.12, which suggest SpringWorks Therapeutics is oversold
- The Bollinger Bands (25) for SpringWorks Therapeutics is (30.52 - 33.74), which suggest SpringWorks Therapeutics is a Sell
- The Bollinger Bands (100) for SpringWorks Therapeutics is (33.31 - 40.03), which suggest SpringWorks Therapeutics is a Sell
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.